Our top pick for
SelectQuote, Inc is an insurance brokers business based in the US. SelectQuote shares (SLQT) are listed on the NYSE and all prices are listed in US Dollars. SelectQuote employs 1,900 staff and has a trailing 12-month revenue of around USD$772.5 million.
|52-week range||USD$16.69 - USD$30.12|
|50-day moving average||USD$24.5041|
|200-day moving average||USD$21.429|
|Wall St. target price||USD$33.11|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.4572|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing SelectQuote stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SelectQuote's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SelectQuote's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, SelectQuote shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
SelectQuote's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$223.3 million.
The EBITDA is a measure of a SelectQuote's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$772.5 million|
|Operating margin TTM||27.8%|
|Gross profit TTM||USD$364.1 million|
|Return on assets TTM||14.28%|
|Return on equity TTM||40.07%|
|Market capitalisation||USD$4.8 billion|
TTM: trailing 12 months
There are currently 7.5 million SelectQuote shares held short by investors – that's known as SelectQuote's "short interest". This figure is 15.3% down from 8.8 million last month.
There are a few different ways that this level of interest in shorting SelectQuote shares can be evaluated.
SelectQuote's "short interest ratio" (SIR) is the quantity of SelectQuote shares currently shorted divided by the average quantity of SelectQuote shares traded daily (recently around 1.2 million). SelectQuote's SIR currently stands at 6.26. In other words for every 100,000 SelectQuote shares traded daily on the market, roughly 6260 shares are currently held short.
However SelectQuote's short interest can also be evaluated against the total number of SelectQuote shares, or, against the total number of tradable SelectQuote shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SelectQuote's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 SelectQuote shares in existence, roughly 50 shares are currently held short) or 0.0606% of the tradable shares (for every 100,000 tradable SelectQuote shares, roughly 61 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against SelectQuote.
Find out more about how you can short SelectQuote stock.
We're not expecting SelectQuote to pay a dividend over the next 12 months.
Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health and property. The company pioneered the direct-to-consumer model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a force of more than 1,000 highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources, scores, and routes high-quality sales leads. The company has three core business lines: SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home. SelectQuote Senior, the largest and fastest-growing business, serves the needs of a demographic that sees 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans from 15 leading, nationally-recognized carriers, as well as prescription drug plan, dental, vision and hearing plans.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.